1.
J Drugs Dermatol
; 20(3): 351-352, 2021 03 01.
Article
in English
| MEDLINE | ID: covidwho-2277097
Subject(s)
COVID-19 Vaccines/adverse effects , COVID-19/prevention & control , Injection Site Reaction/diagnosis , Skin Diseases/diagnosis , Vaccines, Synthetic/adverse effects , COVID-19 Vaccines/genetics , Dermatologists , Female , Health Knowledge, Attitudes, Practice , Humans , Injection Site Reaction/etiology , Injection Site Reaction/therapy , Male , Patient Education as Topic , Physician's Role , Randomized Controlled Trials as Topic , Skin Diseases/etiology , Skin Diseases/therapy , Spike Glycoprotein, Coronavirus/genetics , Vaccines, Synthetic/genetics
2.
J Am Acad Dermatol
; 85(3): e185-e188, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1531497
3.
J Am Acad Dermatol
; 85(5): e313-e315, 2021 11.
Article
in English
| MEDLINE | ID: covidwho-1525829
Subject(s)
COVID-19 , Dermatology , Internship and Residency , Social Media , Humans , Pandemics , SARS-CoV-2
4.
Journal of Clinical and Translational Science
; 5(1), 2020.
Article
in English
| ProQuest Central | ID: covidwho-1157865
ABSTRACT
A multiple linear regression analysis was performed on 12 independent variable predictors to determine the possible case fatality rates at the state level. F, male to female ratio;COPD, congestive obstructive pulmonary disease;CVD, cardiovascular disease;DM, diabetes mellitus;HTN, hypertension;BMI, body mass index. *No Hawaiian or Pacific Islander minority groups reported. &No Hawaiian, Pacific Islander, or Native American minority groups reported.